Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria.
Usman SO, Oreagba IA, Akinyede AA, Agbaje EO, Akinleye MO, Onwujuobi AG, Ken-Owotor C, Adeuja O, Ogunfowokan T, Kogbe S, Owolabi ET, Adeniji H, Busari AW, Hassan OO, Abideen G, Akanmu AS. Usman SO, et al. J Pharmacol Sci. 2020 Nov;144(3):95-101. doi: 10.1016/j.jphs.2020.07.013. Epub 2020 Aug 5. J Pharmacol Sci. 2020. PMID: 32921396 Free article.
Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.
Usman SO, Oreagba IA, Kadri MR, Adewumi OO, Akinyede A, Agbaje EO, Abideen G, Busari AA, Hassan OO, Akinleye MO, Akanmu AS. Usman SO, et al. Eur J Clin Pharmacol. 2021 Sep;77(9):1341-1348. doi: 10.1007/s00228-021-03116-x. Epub 2021 Mar 23. Eur J Clin Pharmacol. 2021. PMID: 33755736
Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether/lumefantrine and atazanavir/ritonavir-based antiretroviral regimen in patients living with HIV.
Usman SO, Oreagba IA, Busari A, Akinyede A, Adewumi O, Kadri MR, Hassan O, Fashina YA, Agbaje EO, Akanmu SA. Usman SO, et al. Saudi Pharm J. 2022 May;30(5):605-612. doi: 10.1016/j.jsps.2022.02.010. Epub 2022 Feb 25. Saudi Pharm J. 2022. PMID: 35693439 Free PMC article.
Phage therapy: A targeted approach to overcoming antibiotic resistance.
Olawade DB, Fapohunda O, Egbon E, Ebiesuwa OA, Usman SO, Faronbi AO, Fidelis SC. Olawade DB, et al. Among authors: usman so. Microb Pathog. 2024 Dec;197:107088. doi: 10.1016/j.micpath.2024.107088. Epub 2024 Oct 29. Microb Pathog. 2024. PMID: 39477033 Free article. Review.
Leveraging artificial intelligence in vaccine development: A narrative review.
Olawade DB, Teke J, Fapohunda O, Weerasinghe K, Usman SO, Ige AO, Clement David-Olawade A. Olawade DB, et al. Among authors: usman so. J Microbiol Methods. 2024 Sep;224:106998. doi: 10.1016/j.mimet.2024.106998. Epub 2024 Jul 15. J Microbiol Methods. 2024. PMID: 39019262 Free article. Review.
14 results